BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 21883102)

  • 1. Proton pump inhibitor discontinuation in long-term care.
    Linsky A; Hermos JA; Lawler EV; Rudolph JL
    J Am Geriatr Soc; 2011 Sep; 59(9):1658-64. PubMed ID: 21883102
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The extent and determinants of prescribing and adherence with acid-reducing medications: a national claims database study.
    El-Serag HB; Fitzgerald S; Richardson P
    Am J Gastroenterol; 2009 Sep; 104(9):2161-7. PubMed ID: 19568229
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of concomitant use of clopidogrel and proton pump inhibitors after percutaneous coronary intervention.
    Banerjee S; Weideman RA; Weideman MW; Little BB; Kelly KC; Gunter JT; Tortorice KL; Shank M; Cryer B; Reilly RF; Rao SV; Kastrati A; de Lemos JA; Brilakis ES; Bhatt DL
    Am J Cardiol; 2011 Mar; 107(6):871-8. PubMed ID: 21247527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effectiveness of national provider prescription of PPI gastroprotection among elderly NSAID users.
    Abraham NS; Hartman C; Castillo D; Richardson P; Smalley W
    Am J Gastroenterol; 2008 Feb; 103(2):323-32. PubMed ID: 18289200
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of proton pump inhibitors with lack of diagnostic indications in 22 Midwestern US skilled nursing facilities.
    Patterson Burdsall D; Flores HC; Krueger J; Garretson S; Gorbien MJ; Iacch A; Dobbs V; Homa T
    J Am Med Dir Assoc; 2013 Jun; 14(6):429-32. PubMed ID: 23583000
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Provision of potentially teratogenic medications to female veterans of childbearing age.
    Schwarz EB; Longo LS; Zhao X; Stone RA; Cunningham F; Good CB
    Med Care; 2010 Sep; 48(9):834-42. PubMed ID: 20706159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Large variations in prescriptions of gastrointestinal medications in hemodialysis patients on three continents: the Dialysis Outcomes and Practice Patterns Study (DOPPS).
    Bailie GR; Mason NA; Elder SJ; Andreucci VE; Greenwood RN; Akiba T; Saito A; Bragg-Gresham JL; Gillespie BW; Young EW
    Hemodial Int; 2006 Apr; 10(2):180-8. PubMed ID: 16623672
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prescribing patterns and predictors of high-level polypharmacy in the elderly population: A prospective surveillance study from two teaching hospitals in India.
    Harugeri A; Joseph J; Parthasarathi G; Ramesh M; Guido S
    Am J Geriatr Pharmacother; 2010 Jun; 8(3):271-80. PubMed ID: 20624616
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk of community-acquired pneumonia in veteran patients to whom proton pump inhibitors were dispensed.
    Hermos JA; Young MM; Fonda JR; Gagnon DR; Fiore LD; Lawler EV
    Clin Infect Dis; 2012 Jan; 54(1):33-42. PubMed ID: 22100573
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mental illness and use of home care nationally in the U.S. Department of Veterans Affairs.
    Miller EA; Rosenheck RA
    Am J Geriatr Psychiatry; 2007 Dec; 15(12):1046-56. PubMed ID: 18056823
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proton pump inhibitors prescribing following the introduction of generic drugs.
    Cammarota S; Bruzzese D; Sarnelli G; Citarella A; Menditto E; Riegler S; Savino IG; Vozzella L; Piccinocchi G; Napoli L; Arpino G; Cuomo R
    Eur J Clin Invest; 2012 Oct; 42(10):1068-78. PubMed ID: 22681176
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Appropriate proton pump inhibitor use among older adults: a retrospective chart review.
    George CJ; Korc B; Ross JS
    Am J Geriatr Pharmacother; 2008 Dec; 6(5):249-54. PubMed ID: 19161927
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proton pump inhibitors and risk for recurrent Clostridium difficile infection.
    Linsky A; Gupta K; Lawler EV; Fonda JR; Hermos JA
    Arch Intern Med; 2010 May; 170(9):772-8. PubMed ID: 20458084
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rising rates of proton pump inhibitor prescribing in US emergency departments.
    Mazer-Amirshahi M; Mullins PM; van den Anker J; Meltzer A; Pines JM
    Am J Emerg Med; 2014 Jun; 32(6):618-22. PubMed ID: 24721025
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Co-prescription of gastro-protectants in hospitalized patients: an analysis of what we do and what we think we do.
    Doherty GA; Cannon MD; Lynch KM; Ayoubi KZ; Harewood GC; Patchett SE; Murray FE
    J Clin Gastroenterol; 2010 Mar; 44(3):e51-6. PubMed ID: 19609216
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reducing the cost of proton pump inhibitors by adopting best practice.
    Hughes JD; Tanpurekul W; Keen NC; Ee HC
    Qual Prim Care; 2009; 17(1):15-21. PubMed ID: 19281670
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A practice-based approach for converting from proton pump inhibitors to less costly therapy.
    Lucas LM; Gerrity MS; Anderson T
    Eff Clin Pract; 2001; 4(6):263-70. PubMed ID: 11769299
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of aspirin and clopidogrel with or without proton pump inhibitors for the secondary prevention of cardiovascular events in patients at high risk for gastrointestinal bleeding.
    Hsiao FY; Tsai YW; Huang WF; Wen YW; Chen PF; Chang PY; Kuo KN
    Clin Ther; 2009 Sep; 31(9):2038-47. PubMed ID: 19843493
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proton pump inhibitor utilization patterns in infants.
    Barron JJ; Tan H; Spalding J; Bakst AW; Singer J
    J Pediatr Gastroenterol Nutr; 2007 Oct; 45(4):421-7. PubMed ID: 18030207
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment patterns and symptom control in patients with GERD: US community-based survey.
    Chey WD; Mody RR; Wu EQ; Chen L; Kothari S; Persson B; Beaulieu N; Lu M
    Curr Med Res Opin; 2009 Aug; 25(8):1869-78. PubMed ID: 19530980
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.